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The importance of vitamin D for musculoskeletal health has long been recognized, and awareness of significant
extra-skeletal effects in health and disease is rapidly emerging. Although it has been possible for many decades
to quantify serum markers of vitamin D deficiency, and to correct deficiency at low cost and with high safety, the
influence of vitamin D status on post-surgical outcomes has only recently been identified as a research topic of
interest. To the present, these data have not been the subject matter of formal review. Accordingly, we conducted a
systematic review to assess the association between perioperative vitamin D status and outcomes after surgery.
The databases of PubMed, Ovid MEDLINE, EMBASE, AMED, CINAHL (EBSCOHost), The Cochrane Databases of Systematic
Review, and PROSPERO were searched through December, 2014 for studies relating to vitamin D and surgery. The
initial search yielded 90 manuscripts. After applying exclusion criteria, 31 studies were eligible for inclusion. Fifteen
studies employed prospective observational designs, 3 used prospective randomized protocols, and 13 report
retrospective database interrogations. The main finding of the present review is that 26 of 31 studies (84%) report
at least one statistically significant worse outcome in patients with low vitamin D status. Five of 31 studies (16%)
found no association. In conclusion, this review supports the hypothesis that hypovitaminosis D is associated with
adverse outcomes after diverse surgical procedures. Future studies should focus on additional surgeries and outcomes,
and on the role of vitamin D supplementation in the improvement of patient safety in participants with low vitamin D
status at the time of surgery.
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Postoperative complicationIntroduction
Vitamin D, a fat soluble steroid hormone formed primarily
by photosynthesis, plays a key role in over 300 metabolic
pathways in humans through a specific nuclear-binding
receptor, and mechanisms for signal transduction that are
expressed in most cells and tissues [1,2]. Although the im-
portance of vitamin D for musculoskeletal health has long
been known, awareness of significant extra-skeletal effects
in health and disease is rapidly emerging [3,4]. Deleterious
effects of vitamin D deficiency on medical and surgical
critical care outcomes have recently been reviewed, and
striking improvements in intensive care mortality after
vitamin D replacement therapy have been reported [5,6].* Correspondence: khogan@wisc.edu
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unless otherwise stated.It has been possible for many decades to quantify serum
markers of vitamin D deficiency, and to correct deficiency
at low cost and with high safety, however, the influence of
vitamin D status on post-surgical outcomes is less well-
recognized [3,4]. Whereas critical care outcomes have
generally been reported in a shared core of journals, post-
surgical outcomes appear in diverse, specialty-oriented
publications that may be less likely to cross-reference one
another (see below). Vitamin D deficiency is defined by
the Institute of Medicine (IOM) as a 25(OH)D of less than
20 ng/ml [3]. Vitamin D insufficiency is defined as a
25(OH)D of 21–29 ng/ml [3]. In keeping with these defi-
nitions, the estimated prevalence of vitamin D insuffi-
ciency is as high as 50 to 80% in the general population
[4]. Children, young adults, middle-aged adults and elderly
adults are at comparably high risk for vitamin D deficiency
and insufficiency [4]. Accordingly, it is the aim of thetral. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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data that correlates perioperative vitamin D status with
post-surgical outcomes for analytical validity, clinical val-
idity and clinical utility, and to identify research priorities
with the potential to streamline their impact on public
health and patient safety.
Methods
Inclusion criteria
A systematic review to detect published relationships in
the peer-reviewed literature between serum vitamin D
status and post-surgical outcomes was conducted. The
study protocol was developed to ascertain both observa-
tional studies and controlled trials that compare one or
more serum indices of vitamin D status with any adverse
outcome after surgery. The primary inclusion criteria
comprised measurement of serum 25-hydroxy vitamin D
(25(OH)D) and/or 1,25-dihydroxyvitamin D (1,25(OH)2
D) in the interval spanning 12 weeks before to 12 weeks
after any type surgery. This time frame was chosen in
keeping with the stability and kinetics of serum 25(OH)D,
the most widely used circulating vitamin D biomarker,
over time [7]. Any measure of a postoperative outcome or
complication was accepted. Outcomes directly related to
the target tissue of surgery (e.g., surgical site infection),
and those related to tissues other than the target tissue
of surgery (e.g., hospital-acquired infection, in-hospital
mortality) were incorporated into the search. Secondary
outcomes were also reviewed. Adult and pediatric in-
vestigations with female and male participants of any
age qualified for inclusion. The study protocol was de-
veloped to review both retrospective and observational
prospective (cross-sectional, case–control and cohort)
study designs, and interventional studies, both random-
ized and non-randomized, as long as serum vitamin D
status was reported before and after treatment and sur-
gery. Because the entire evidence database was required
to address the aims of the review, studies were not ex-
cluded on the basis of their methodological quality or
sample size. Publication dates were not restricted.
Exclusion criteria
Case reports, letters, stand-alone abstracts, narrative re-
views, animal studies, duplicates, editorials and articles
not available in full English translation were excluded.
Investigations reporting only the prevalence of sub-
threshold values before surgery that were not tested for
correlation to surgical outcomes were omitted, although
citation to these references are frequently cited in the
manuscripts reviewed herein. Studies that correlated
preoperative vitamin D status with other pre-operative
values and pathologies in the absence of post-operative
outcomes, or that correlate vitamin D status with in-
creased need for surgery independent of adverse post-surgical events, were similarly eliminated from review.
Manuscripts describing the direct effects of surgery on
serum vitamin D levels (e.g., vitamin D status as an out-
come after renal transplantation and gastric surgery),
and hypocalcemia after parathyroid and thyroid surgery
(e.g., secondary hyperparathyroidism after renal trans-
plantation) were not considered.
Search strategy
Potentially relevant articles were identified by a compre-
hensive search of the peer-reviewed literature in publicly
available computerized databases. Electronic databases
searched were: PubMed, Ovid MEDLINE, EMBASE,
AMED, CINAHL (EBSCOHost), The Cochrane Data-
bases of Systematic Review, and PROSPERO. The search
was performed with the assistance of a librarian experi-
enced in systematic reviews following PRISMA (Preferred
Reporting Items for Systematic Reviews and Meta-
Analyses) statement guidelines, a checklist and phase flow
diagram constructed to enhance the quality of systematic
reviews [8]. A structured search strategy for MEDLINE
was based on a controlled vocabulary and relevant key
terms configured for breadth to prioritize sensitivity. Man-
uscripts were identified using one, or a Boolean combin-
ation of two or more, of the following search terms:
“vitamin D”; “25(OH)D (calcifediol)”; “25(OH)D (calcife-
diol) level”; “1,25-dihydroxyvitamin D3 (calcitriol)”; “1,25-
dihydroxyvitamin D3 (calcitriol) level”; “surgery outcome”;
“surgery complication”; “postoperative outcome”; “postop-
erative complication”; and diverse surgical procedures.
These terms were then adapted for other databases. Initial
search results were followed by targeted author searches
to detect additional sources. References of included manu-
scripts and accompanying editorials, bibliographies of re-
view articles, letters to editors and author responses to
primary sources, and clinical trial registries were scanned
for further citations. Included manuscripts were searched
using the Related Articles feature in PubMed, Cited Refer-
ence Search in ISI Web of Science, and Cited By and Re-
lated Articles features of Google to identify further
references. The title and abstract of each citation was
reviewed by two independent reviewers, and potentially
eligible articles were retrieved for scrutiny in full text. Dis-
crepancies in eligibility between reviewers were resolved
by consensus. The initial search was done from June, 2014
to December, 2014.
Data extraction
Standardized data extracted from each publication that
met inclusion criteria consisted of: PubMed ID number;
author listing; journal; year of publication; number and
location of participating centers; participant number,
gender, age, and type of surgery of the population sam-
ple; type of study and design; inclusion and exclusion
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gery; marker of vitamin D status that was measured;
vitamin D analysis method; vitamin D status reporting
and statistical analysis methods (i.e., as a categorical vari-
able by threshold, quintiles, or as a continuous variable);
specific primary and secondary outcomes sought; methods
of scoring outcomes; time frame for scoring outcomes
after surgery and the length of clinical follow up; presence
or absence of power calculation for a primary outcome;
methods of descriptive and inferential statistical analysis;
presence or absence of at least one multivariate analysis;
significant positive and negative correlations of periopera-
tive vitamin D status and observed primary and secondary
outcomes; effect size; and study strengths, weaknesses,
and gaps. The extracted data was verified by a second re-
viewer to reduce errors and bias.
Results
The titles and abstracts of 90 manuscripts were found to
potentially fulfill search criteria. After application of inclu-
sion standards and full text review, 31 manuscripts
remained for inclusion in 28 different journals (Figure 1).
Table 1 provides summary data of retrieved manuscripts
grouped by the type of surgery and by the date of publica-
tion. Of 31 manuscripts meeting inclusion criteria, 15
used prospective observational designs, 3 applied pro-
spective randomized protocols, and 13 report retrospect-
ive interrogations of databases. In aggregate, post-surgical
outcomes were scored in 16,195 individuals with study
population sample sizes varying from 18 to 4,418 patients.
The main finding of the present review is that 26 of 31
publications report at least one statistically significant cor-
relation between low perioperative vitamin D status and at
least one deleterious postoperative outcome. In most ac-
counts, the clinical significance of low perioperative vita-
min D status is substantial. For example, Ducloux et al.Figure 1 Diagram of the manuscript selection process from
database search to inclusion.observed an 8% increased risk of cancer after kidney
transplantation for each 1 ng/mL decrease in serum
25(OH)D, and a 4-fold greater risk of cancer overall in pa-
tients with low vitamin D status [22]. Falkiewiscz et al.
found an 8-fold greater risk of delayed renal graft failure
with perioperative vitamin D deficiency [23]. Patients with
preoperative serum 25(OH)D less than 30 ng/mL were at
3- to 4-fold greater risk for hospital-acquired and surgical
site infections in data analyzed by Quraishi et al. [21].
Low vitamin D status in the near transplant interval pre-
dicts a 3-fold greater risk of moderate to high grade organ
rejection and 5-fold greater mortality in the first year after
pulmonary transplantation in patients investigated by
Lowery et al. [28].
Five publications observed no significant difference in
the incidence of adverse outcomes between groups with
lower and higher vitamin D status [11,14,15,17,34].
However, in none is it clear that no difference truly ex-
ists, or if design and conduct constraints preclude detec-
tion of a correlation. For example, Jansen et al. concede
“missing data could be responsible for lack of power to
show any significance at all”. [15]. Similarly, Unnanun-
tana conclude “Considering that our definition of vita-
min D deficiency was determined at higher serum levels
than previously reported, this could potentially explain
the apparent lack of association between vitamin D sta-
tus and the attainment of functional milestones”. [11]. In
accounting for failure to observe an association between
perioperative vitamin D concentrations and cardiac sur-
gery outcomes in a retrospective analysis of an adminis-
trative database, Turan et al. suggest that outcomes after
the cardiovascular procedures that they examined may
be “overwhelmingly determined by other baseline and
surgical factors” [34]. Sixteen manuscripts describe the
lack of statistical significance of one or more associations
between vitamin D status and a diversity of secondary out-
comes. One report suggests a U-shaped relationship be-
tween serum 25(OH)D concentrations and adverse
cardiovascular outcomes after cardiac surgery at levels
above 40 ng/mL [35]. The correlation was later refuted in
a follow-up investigation by the same investigators [36].
No other deleterious associations with high vitamin D sta-
tus were disclosed.
Vitamin D status was first measured in the interval
from 2 weeks before surgery to immediately after
anesthetic induction in 22 studies. In 2 reports, vitamin
D status was first tested up to 2 weeks after surgery
[23,33]. Vitamin D status was first determined in the
interval from 2 weeks before to 12 weeks after surgery
in 2 investigations [25,26]. In 4 reports, vitamin D status
was assessed in the interval from 12 weeks before sur-
gery to 4 weeks after surgery [9,21,20,34]. Lowery et al.
examined vitamin D status in the interval from 12 weeks
before to 12 weeks after surgery [28]. In 13 reports,
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5 reports by liquid chromatography and tandem mass
spectrometry (LC-MS/MS), in 1 report by high pressure
liquid chromatography (HPLC), and in 2 reports by che-
moluminescent immunoassay (CIA). Five teams of inves-
tigators failed to indicate their methods of measuring
serum 25(OH)D. Two reports provide results from both
25(OH)D by RIA and 1,25(OH)2D by enzyme-linked im-
munosorbent assay (ELISA), 1 from both 25(OH)D by
RIA and 1,25(OH)2D by LC-MS/MS, 2 from both
25(OH)D by RIA and 1,25 (OH)2D by unreported
methods, and 1 from 1,25(OH)2D alone using RIA.
In 9 manuscripts, vitamin D status is analyzed and re-
ported as a continuous variable. Three of the 9 also
analyze and report vitamin D status as a categorical vari-
able, or as a quintile. In 22 investigations, vitamin D status
was solely analyzed and reported as a categorical (i.e.,
dichotomized or trichotomized) variable. 25(OH)D
thresholds for the lowest analyzed cutoff vary widely from
5 ng/mL (1 report), 10 ng/mL (4 reports), 12 ng/mL (2 re-
ports), 16 ng/mL (2 reports), 20 ng/mL (7 reports), to
30 ng/mL (4 reports) between studies (Table 1). The num-
ber and proportion of participants in categories defined
and analyzed by cutoff values were broadly unequal be-
tween categories in 19 of the 22 investigations. Twenty-six
of 31 investigations failed to perform a power analysis to
assure that overall sample sizes were adequate to detect a
significant difference based on estimated variances around
anticipated sample means. Twenty-three of 31 investiga-
tions performed one or more multivariate analyses
[9,10,12,13,16-18,21,22,24-27,30-39].
Discussion
The aim of the present contribution is to provide a sys-
tematic review of investigations published in peer-
reviewed periodicals that compare risks for diverse
post-surgical outcomes with perioperative measures of
vitamin D status based on a search designed to include
any surgery in both adult and pediatric patients. Sur-
prisingly, no publications that satisfy inclusion criteria
were published before 2008, although validated indices
of vitamin D status and quantifiable measures of post-
operative outcomes have been available for decades.
The absence of earlier manuscripts most probably re-
flects failure of clinicians and investigators to recognize
the potential for adverse, extra-skeletal consequences of
low vitamin D status in acute care settings as a research
question of interest. Correlation of vitamin D status
with the risk and severity of over 130 chronic non-
skeletal conditions including death due to cardiovascu-
lar disease, cancer and other causes is contentious
[40,41]. Compared to susceptibilities that may require
decades to evolve, a first strength of reports incorpo-
rated in the present review is that adverse outcomes arelinked in time to a surgical intervention that is shared
between participants with lower and higher vitamin D
status. A second strength is that medical and surgical
records in the interval surrounding surgery are rich
with objective data including physical examinations, la-
boratory values, past medical histories and the like, so
that background variables including co-morbidities,
inter-current medications, and body mass indices that
influence markers of vitamin D status as well as surgi-
cal outcomes may be closely matched, and results that
may arise from reverse causation otherwise controlled.
A further strength is that evidence that is evenly di-
vided between prospective and retrospective study de-
signs points to shared observations. Statistically
significant and clinically important correlations of ad-
verse outcomes after surgery with low vitamin D status
in 26 of 31 manuscripts suggest that vitamin D status is
a predictor of extra-skeletal disorders for which predis-
positions may be diagnosed and deficiencies corrected
prior to surgical procedures. In turn, publication of 5
reports that do not identify statistically significant cor-
relations, and lack of statistical significance of one or
more associations between vitamin D status and a di-
versity of secondary outcomes in 17 of 31 manuscripts,
implies that positive publication bias alone is insuffi-
cient to account for an overall association.
Another surprising feature of the present review is the
diversity, severity and magnitude of increased risks for
detrimental outcomes that span suboptimal surgical out-
comes to grievous postoperative complications including
surgical site and hospital-acquired infections, graft fail-
ure, cancer, myocardial infarction, low cardiac output
syndrome, stroke, ICU and hospital length of stay, and
in-hospital and one-year mortality after surgery. While
not the objective of the reviewed publications, virtually
all inquiries confirm a very high prevalence of vitamin D
deficiency at the time of surgery in view of 25(OH)D
levels recommended by the Institute of Medicine
(20 ng/mL) and The Endocrine Society (30 ng/mL) to
maintain skeletal health [3,42]. Several studies suggest
that vitamin D status at the time of surgery is the most
relevant predictor of long term outcomes compared to
vitamin D status in days to weeks after surgery, and that
minimal benefits can be gained by supplementation at
the time of surgery or thereafter [24,29]. Survey of publi-
cations summarized in Table 1 as a whole demonstrates
that most patients arriving for surgery are malnourished,
and reveals that the patient safety and public health con-
sequences of malnutrition may be serious.
Inspection of Table 1 further highlights sizeable gaps
in the quality and quantity of evidence of potential utility
in guiding clinical decisions. Standardization of mea-
sures chosen for determination of vitamin D status as an
independent variable must be a top priority of future
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idity. Endocrine Society Task Force guidelines recom-
mend measurement of circulating 25(OH)D rather than
1,25(OH)2D to assess vitamin D status, or both, but dis-
parages analysis of 1,25(OH)2D alone [3]. 25(OH)D as-
says using LC-MS/MS methods calibrated with National
Institutes of Standards and Technology (NIST) stan-
dards are to be preferred over RIA- and ELISA-based
technologies that may over-estimate true 25(OH)D con-
centrations [43]. Because precision and predictive power
differ between kits and manufacturers, when RIA- and
ELISA-based methods are chosen, investigators must
provide the source, assure calibration with consensus
standards, and cite references of comparative accuracy.
Incorporation of plasma and urine measures of vitamin
D binding protein (VDP) and free 25(OH)D is encour-
aged in order to interpret fluctuations in 25(OH)D levels
that may arise from pre-operative and post-operative
fluid management, nutrition, health status and other fac-
tors known to shift in the perioperative setting [37,44].
The plasma half-life of 25(OH)D is about 3 weeks.
25(OH)D is 80%-90% bound to VDP, with its half-life
measured in days. For these reasons, a molar ratio of
25(OH)D to VDP concentrations may provide a useful
index of vitamin D biological activity of value in longitu-
dinal study designs. Given 25(OH)D and VDP kinetics,
determination of vitamin D status in the perioperative
interval should be further standardized to include at
least one measure in the time period 2 weeks before sur-
gery to incision. In addition, funding sources and journal
editors must expect strong justifications for not acquir-
ing serial vitamin D assays at the time of scheduled
post-operative outcome measures in order to fill gaps in
published data.
Multiple opportunities are available to improve the
clinical validity of presumptive correlations between
perioperative vitamin D status and post-operative out-
comes. A minority of investigations in the present review
properly report and analyze vitamin D status as a con-
tinuous variable. Thresholds and cutoffs that compress
vitamin D status into 2 or 3 categories based on skeletal
outcomes are hotly debated among experts [45]. No
threshold levels have been validated for extra-skeletal
outcomes. Whereas minimal daily requirements and levels
of vitamin D to avoid traits of musculoskeletal deficiency
fall most reasonably in the range of 20 to 30 ng/mL,
25(OH)D concentrations necessary for optimal health,
and 25(OH)D concentrations necessary for optimal health
during recovery from surgery and critical care, are know-
able but unknown [46]. Clearly, optimal levels of serum
25(OH)D that may differ between patients, surgeries and
outcomes must be sought, validated and replicated. A key
path toward resolution of thresholds with clinical validity
will be to first correlate 25(OH)D as a continuous variableto outcomes of interest. Analysis and reporting of vitamin
D status as a categorical variable may be considered as a
supplement to analysis of 25(OH)D concentration as a
continuous variable of potential use to frame relationships
with collateral data sets and arbitrary definitions (e.g., “de-
ficient”, “inadequate”, “sufficient”, “normal”), but categor-
ical variables must not be considered a substitute for more
rigorous and comprehensive methods. Uniform de-
scriptive and inferential statistical methods and reports
appropriate for analysis of continuous variables will en-
able investigations to be compared with one another
without loss of data that is inevitable when categorical
variables above and below an arbitrary threshold are
tested and described alone. High levels of clinical valid-
ity further rely on standardization of outcome defini-
tions and measures as dependent variables within and
between surgical specialties and sub-specialties coupled
to standardized evaluation time frames.
Manuscripts included in the present review illustrate
that superior experimental designs are required to disen-
tangle potential correlations between perioperative vita-
min D status and complications after surgery. Because
testing for and correcting vitamin D deficiency is low in
cost, safe and effective, inappropriate and inadequate de-
signs, i.e., underpowered “pilot” studies, are a temptation
to be avoided. Population sample sizes of the present data
are often too small to permit ironclad conclusions on the
basis of a single publication. Failure to perform a power
analysis for a primary outcome in 26 of 31 reports is an
error that must be avoided by investigators, and that must
not be tolerated by funding agencies, editors, reviewers
and readers. Interpretation of results between studies re-
lies on explicit provision of inclusion and exclusion cri-
teria, and matching of background variables that modify
assays of vitamin D status and outcome measures. No in-
vestigation to the present has enrolled matched partici-
pants within no-surgery arms. Most studies are confined
to a single center despite internationally standardized
measures of vitamin D status and outcome specific mea-
sures. To circumvent bias, unmeasured cofounders and
insufficient power, investigations directed to interrogation
of administrative or other databases using propensity
score matching must satisfy requirements that are often
skirted [47]. Future prospective trial designs in which vita-
min D status is manipulated in the perioperative interval
must measure concentrations at baseline before surgery,
and then administer vitamin D analogs guided by pre-set
target concentrations rather than by fixed doses. Investiga-
tors should consider experimental designs that are a priori
compliant with Newcastle-Ottawa Scale guidelines for ob-
servational studies, and with the Cochrane Risk Assess-
ment Tool for randomized controlled trials in order that
future evidence across studies for diverse outcomes may
be meaningfully compared [48,49].
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lent in the manuscripts of the present review. Investiga-
tors should target enrollment that satisfies normal
distributions of both vitamin D status and outcome
measures. When non-parametric inferential methods
and data transformations are employed, publications
should declare which assumptions for parametric ana-
lysis have been violated. If odds ratios and hazard ratios
are reported, authors must make it simple for the reader
to locate the number and proportion of patients with a
given outcome that may have contributed to a statistically
significant association, and provide confidence intervals to
support comparisons with the present and future data of
others. In articles of the present review, authors are incon-
sistent in using multivariate analyses to correct for con-
founders (e.g., age, gender, body mass index), and in
correcting for multiple comparisons that encroach on
available statistical power. Statistical methods that test for
the relative effect sizes of multiple outcomes should be
employed whenever appropriate [50].
The present systematic review underscores the need for
replication and extension of published results, as well as
the need for future investigations of vitamin D status as a
predictor of other outcomes after other types of surgery
and anesthesia. For example, vitamin D deficiency in-
creases the risk of cognitive decline and dementia in older
adults, but the acute and chronic effects of low vitamin D
status at the time of surgery on postoperative delirium,
cognitive dysfunction, and the onset and progression of
dementia after surgery are unknown [51,52]. Enrollment
of a much broader diversity of age groups from infancy to
senescence, co-morbidities, and ethnicities together with
cohorts matched for gender and gravidity is compelling in
view of presently available data. Vitamin D synthetic and
metabolic pathways are highly polymorphic. Shared serum
levels of free 25(OH)D may therefore carry distinct health
implications in populations with divergent pharmacoki-
netic and pharmacodynamic genetic backgrounds. To this
end, addition of molecular biomarkers including genom-
ics, epigenomics, and assays of expressed damage associ-
ated patterns (DAMPs) (e.g., by mass spectrometry of
serum samples) to perioperative vitamin D protocols is
clinically and scientifically warranted, and very likely to be
informative in comparisons of extreme phenotypes e.g., of
bottom vs. top quintiles of vitamin D status and specific
outcomes [53]. Of note, hypovitaminosis D may itself be a
marker for deficiencies of other vitamins, nutrients and
co-factors in the perioperative interval, with consequences
that may also have been overlooked after surgery. As
knowledge of the effects of malnutrition at the time of
surgery expands, submission and publication of well-
designed and conducted studies with negative results
will be particularly crucial as a counterweight to posi-
tive publication bias.While awaiting publication of data with greater breadth,
depth and rigor, we propose that the contents of the
present systematic review comprise a message of present
day clinical relevance. There is no question that a large
proportion of patients undergo surgery and anesthesia in
developed and developing nations with moderate to pro-
found levels of vitamin D deficiency. Publications col-
lected and reviewed in the present contribution provide
ample evidence that many patients are at substantially
heightened risk for calamitous outcomes by virtue of their
low vitamin D status at the time of surgery. Nevertheless,
contemporary practice is not to test for, or to supplement,
vitamin D concentrations before surgical procedures. We
propose, to the contrary, that manuscripts reviewed here
provide sufficient evidence to shift the burden of proof to
those who believe that performing elective surgery on
vitamin D deficient patients comports with the highest
standards of patient safety and public health. Until such
data is available, and in consideration of the low cost,
safety and efficacy of supplementation of a nutrient (i.e.,
not a drug, foreign chemical, or blood product), we fur-
ther propose that evidence is sufficient at present to sup-
port testing and supplementation to target levels as a
practical default. We contend that learning whether it is
safe to deviate far from ancestral levels of vitamin D in pa-
tients facing the trauma of surgery, and the demands of
healing, is an overarching question, and that until this an-
swer is in hand measurement and supplementation as in-
dicated is preferred to the no-action approach of the
status quo [54].
We are aware of several limitations of the present sys-
tematic review. A first is the possibility that one or more
publications may have eluded our scrutiny. A second
limitation is that the heterogeneity of patients, surgeries,
methods of measuring vitamin D status and postopera-
tive outcomes, statistical inference and reporting pre-
cludes formal analysis of the quality of evidence across
studies, and combination of the studies for meta-analysis
at present [55]. A third limitation is that none of the
manuscripts were configured to illuminate mechanisms
of the interaction between perioperative vitamin D status
and outcomes after surgery. In the absence of well-
settled mechanisms, close matching of preoperative
health status and co-morbidities at the time of surgery,
and observations made in phase with a specific surgical
intervention, controls but does not fully eliminate the
possibility that vitamin D status is a bystander or proxy
for ill health and reverse causation. Randomized con-
trolled trials are required to balance bias and unmeas-
ured confounders, however evidence from the present
manuscripts suggests that IRB approval of placebo-based
protocols, and voluntary enrollment in placebo cohorts,
may not be trivial undertakings if full disclosure of
present data is furnished to candidate participants.
Iglar and Hogan Patient Safety in Surgery  (2015) 9:14 Page 9 of 10Conclusions
In conclusion, the present systematic review establishes
that a large majority of prospective and retrospective in-
vestigations report that low perioperative vitamin D sta-
tus is associated with a diversity of adverse outcomes
after surgery with statistical significance and clinical im-
portance. Taken individually, manuscripts included in
the present contribution must be viewed with caution in
light of methods that may over-estimate vitamin D sta-
tus, that are confined to categorical analysis and report-
ing, and that may comprise heterogeneity that limits
comparisons between studies. Taken together, manu-
scripts included in the present contribution provide evi-
dence that an opportunity for substantial improvement
in patient safety and public health is expedient. Practice
improvements of comparable potential magnitude with
negligible cost and exemplary safety and efficacy are
rare, and raise deliberation of the ethical implications of
choosing not to test for, and not to treat, low vitamin D
status in advance of surgery.
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